1. Home
  2. TWI vs LBRX Comparison

TWI vs LBRX Comparison

Compare TWI & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan International Inc. (DE)

TWI

Titan International Inc. (DE)

HOLD

Current Price

$8.16

Market Cap

691.3M

Sector

Industrials

ML Signal

HOLD

LBRX

LB Pharmaceuticals Inc

N/A

Current Price

$30.64

Market Cap

602.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TWI
LBRX
Founded
1890
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
691.3M
602.6M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
TWI
LBRX
Price
$8.16
$30.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$12.00
$47.00
AVG Volume (30 Days)
1.4M
300.6K
Earning Date
04-30-2026
05-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.69
N/A
Revenue Next Year
$4.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.03
$13.40
52 Week High
$11.70
$32.91

Technical Indicators

Market Signals
Indicator
TWI
LBRX
Relative Strength Index (RSI) 52.31 65.02
Support Level $8.03 $21.90
Resistance Level $8.45 N/A
Average True Range (ATR) 0.37 1.92
MACD 0.07 0.43
Stochastic Oscillator 62.98 75.71

Price Performance

Historical Comparison
TWI
LBRX

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.

Share on Social Networks: